Chronic effects of Campylobacter infection

Microbes and Infection

Volumn 4, Issue 4, 2002, Pages 399-403

  Nachamkin, Irving ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoimmune diseases; Campylobacter; Gastrointestinal infections; Guillain Barr syndrome; Post infectious polyneuropathy

Indexed keywords

BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CAMPYLOBACTER JEJUNI; CHRONICITY; CLINICAL TRIAL; DISEASE COURSE; DISEASE MODEL; GASTROENTERITIS; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HOST; HUMAN; INFECTION COMPLICATION; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW;

CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; GASTROENTERITIS; GUILLAIN-BARRE SYNDROME; HUMANS; MOLECULAR MIMICRY; RISK FACTORS;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER JEJUNI;

EID: 0036217350     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01553-8     Document Type: Review

References (49)

1. Human autoimmune neuropathies
2. Workshop summary and recommendations regarding the development of Guillain-Barré syndrome following Campylobacter infection
3. Clinical and epidemiologic features of Guillain-Barré syndrome
4. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain B-N-acetylglucosamine residues
5. Association of Campylobacter jejuni serotype and anti-ganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome
6. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome
7. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: Molecular mimicry and host susceptibility
8. Campylobacter jejuni and Guillain-Barré syndrome in Mexico City: A prospective culture based analysis of O serotypes associated with the disease
9. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains
10. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher Syndromes
11. Campylobacter jejuni infection and Guillain-Barré syndrome
12. Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome
13. Differentiation of Campylobacter jejuni serotype O19 strains from non-O19 strains by PCR
14. Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barré Syndrome
15. Genetic and biochemical evidence of a Campylobacter jejuni capsular polysaccharide that accounts for Penner serotype specificity
16. The distribution of ganglioside-like moieties in peripheral nerves
17. Anti-GD1a antibody distinguishes axonal from demyelinating forms of Guillain-Barré syndrome
18. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies
19. Anti-GD1a ganglioside antibodies in peripheral motor syndromes
20. Acute motor axonal neuropathy: An antibody-mediated attack on axolemma
21. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy
22. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations
23. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3- diamino-2,3-dideoxy-D-glucose
24. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside structure
25. Lipopolysaccharides of Campylobacter jejuni serotype O:19: Structures of O antigen chains from the serostrain and two bacterial isolates from patients with Guillain-Barré syndrome
26. Characterization of a post-translational modification of Campylobacter flagellin: Identification of a sero-specific glycosyl moiety
27. Identification and characterization of genes required for post-translational modification of Campylobacter coli VC167 flagellin
28. Evidence for a system of general protein glycosylation in Campylobacter jejuni
29. Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384
30. Multiple N-acetyl neuramic acid synthetase (neuB) genes in Campylobacter jejuni: Identification and characterization of the gene involved in sialyation of lipo-oligosaccharide
31. Phase variation of a B-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni
32. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences
33. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States
34. The economic burden of Campylobacter associated Guillain-Barré syndrome
35. Guillain-Barré syndrome: Epidemiology of an outbreak
36. Outbreak of Guillain-Barré syndrome associated with water pollution
37. HLA class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their associations with preceding Campylobacter jejuni infection
38. Guillain Barré syndrome: Clinical and immunological aspects
39. P2-Reactive T cells in inflammatory demyelination of the peripheral nerve
40. Insights into Campylobacter jejuni inducted Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis
41. Experimental Campylobacter jejuni infection in the chicken: An animal model of axonal Guillain-Barré syndrome
42. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b
43. High affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: Reexamination of GD1a immunolocalization